Anchora Medical develops a single-use suturing device that utilizes stainless steel anchors to create running or interrupted stitches in soft tissue during endoscopic procedures. This technology simplifies the complex and time-consuming process of suturing in minimally invasive surgeries, enhancing efficiency and precision.

Butterfly Medical has developed a minimally invasive, implantable device that treats Benign Prostatic Hyperplasia (BPH) by retracting lateral lobes without cutting or burning tissue. This non-surgical solution offers a reversible treatment option for the approximately 30 million men worldwide experiencing BPH symptoms, significantly improving their quality of life.

Cardiac Success develops the Vsling, a transcatheter ventricular repair device designed to reshape the left ventricle in patients with heart failure and reduced ejection fraction. This device addresses the deterioration of cardiac function by initiating therapeutic remodeling, thereby improving symptoms and enhancing patients' quality of life.

E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.

Filterlex Medica develops the CAPTIS® full-body embolic protection device, designed to capture and remove embolic particles during catheter-based structural heart procedures like TAVI. This technology reduces the risk of stroke and other complications by preventing the migration of emboli to the brain and distal organs.

The startup specializes in the production of hyaluronic acid dermal fillers utilizing a unique crosslinking mechanism that preserves the integrity of natural hyaluronic acid chains. This technology enables effective non-invasive aesthetic treatments for visible wrinkles and facial reshaping, providing clients with a more natural appearance.

Healium Medical develops the Echomplish RDN™ Ablation System, which utilizes Dual-Mode Ultrasound Technology (DMUT) for non-contact, continuous ablation therapy with real-time tissue monitoring. This system addresses the challenges of traditional atrial fibrillation treatments by providing precise ultrasonic energy for safe and rapid lesion placement, enhancing procedural efficiency and patient safety.

Index provides an all-in-one analytics platform that connects disparate data sources for unified querying. Its core feature leverages AI to translate natural language questions directly into executable SQL queries and visualizations. The platform enables automated sharing of up-to-date metrics and insights via dashboards and direct integrations with collaboration tools like Slack.

Provides a global payment platform that automates mass payments, tax compliance, and foreign exchange for businesses. By integrating with accounting software and offering a customizable API, it streamlines cross-border transactions in over 30 currencies, reducing manual workload and ensuring accurate, compliant financial operations.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

The startup has developed a kidney health monitoring device that automatically tracks urine output and predicts acute kidney injury (AKI) occurrence through real-time assessment. This technology enables clinicians to manage fluid levels effectively, reducing the need for extensive interventions and minimizing patient hospital stays and associated costs.

Sofwave™ utilizes Synchronous Ultrasound Parallel Beam Technology to stimulate collagen production, effectively lifting the eyebrows, neck, and submental areas while reducing fine lines and wrinkles. This non-invasive treatment offers quick sessions with minimal downtime, making it suitable for various skin types and colors.

Supra provides a platform for cross-border payments that enables businesses to transact in over 40 countries with competitive currency conversion rates and reduced transaction times. The service streamlines international payment processes, minimizing bureaucratic hurdles and enhancing cash flow management for importers and exporters.

Trisol Medical develops a Transcatheter Tricuspid Replacement Valve designed to eliminate Tricuspid Regurgitation while preserving Right Ventricle function, addressing the needs of approximately 1.6 million patients in the U.S. who are unsuitable for surgical intervention. The valve features a nitinol frame and dome-shaped leaflet, allowing for easy implantation across various annulus sizes and providing a fully percutaneous solution.